Ledger.Open graph →
SEC Form D · filed July 7, 2021

Veralox Therapeutics Inc

Offering
$22.8M
Sold
$14.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FREDERICK, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Jeffrey W. Strovel · Frederick, MDExec · DirectorBenjamin W. Scruggs · Frederick, MDDirectorJamie W. Stiff · Frederick, MDDirectorKatie W. Ellias · Frederick, MDDirectorAlex W. Martin · Frederick, MDDirectorMarc K. Furstein · New York, NYExec · DirectorChristopher W. Gagliardi · Frederick, MDDirectorMilena Alberti · Cleveland, OHExec · DirectorBenjamin W. Scruggs · Frederick, MDDirectorJamie W. Stiff · Frederick, MDDirectorKatie W. Ellias · Frederick, MDDirectorChristopher W. Gagliardi · Frederick, MDDirectorAlex W. Martin · Frederick, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗